J&J | Actif À Court Terme



Current Assets Changement Date
AbbVie USD 27.68B 2.09B 2025-03
Abbott USD 24.47B 1.32B 2025-06
Amgen USD 26.73B 195M 2025-06
AstraZeneca USD 28.94B 2.8B 2025-06
Baxter International USD 7.04B 1.82B 2025-03
Bayer EUR 34.83B 388M 2025-03
Becton, Dickinson and Co. USD 9B 331M 2025-06
Biogen USD 7.97B 341.7M 2025-06
Boston Scientific USD 7.34B 415M 2025-03
Bristol-Myers Squibb USD 33.22B 2.44B 2025-06
CONMED USD 657.78M 18.78M 2025-06
Cooper Companies USD 2.13B 138.7M 2025-04
Dexcom USD 5.03B 476.4M 2025-06
Edwards Lifesciences USD 6.21B 72.7M 2025-03
Eli Lilly USD 49.85B 8.59B 2025-06
Gilead Sciences USD 14.72B 2.18B 2025-06
GlaxoSmithKline GBP 17.67B 412M 2025-06
Globus Medical USD 1.73B 19.79M 2025-06
Hologic USD 3.42B 212.7M 2025-06
Insulet USD 2.28B 48.7M 2025-06
Integra LifeSciences USD 1.14B 35.58M 2025-06
Intuitive Surgical USD 12.47B 592.4M 2025-06
J&J USD 71.55B 15.66B 2025-03
Medtronic USD 23.81B 1.3B 2025-04
Merck USD 37.07B 1.56B 2025-06
Merit Medical Systems USD 923.07M 35.56M 2025-06
Novartis USD 25.94B 831M 2025-06
Pfizer USD 43.7B 2.16B 2025-06
Regeneron Pharmaceuticals USD 16.86B 712.2M 2025-06
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 37.02B 7B 2025-06
Stryker USD 13B 19M 2025-06
Tandem Diabetes Care USD 614.82M 48.62M 2025-06
Teva Pharmaceutical Industries USD 12.62B 1.09B 2025-06
Vertex Pharmaceuticals USD 10.43B 419.1M 2025-06
Zimmer Biomet Holdings USD 5.05B 536.3M 2025-06
Zoetis USD 5.92B 46M 2025-06


J&J Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.